Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion
- PMID: 7562405
- DOI: 10.1002/jps.2600840605
Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion
Abstract
We have previously established that the relative concentrations of propylene glycol and ethanol as a binary solvent system have a significant effect on the skin penetration of 2% solutions of minoxidil at 50 microL/cm2. The present work extends these studies and investigates the penetration of minoxidil from the different vehicle combinations as functions of application volume and occlusion. Decreasing the application volume has a variable effect which depends on vehicle composition. Penetration of minoxidil from 100% ethanol solutions decreased linearly with application volume. Generally, irrespective of the volume applied, the penetration of minoxidil increased with increasing ethanol fraction with a maximum penetration at 90% ethanol. Penetration from all the formulations was enhanced upon occluding the skin, with greatest increase evident in solutions with higher volatile fraction. Penetration of minoxidil in vivo showed trends similar to those seen in vitro.
Similar articles
-
Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.J Pharm Sci. 1994 Oct;83(10):1508-10. doi: 10.1002/jps.2600831026. J Pharm Sci. 1994. PMID: 7884676
-
Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.J Pharm Sci. 1992 Aug;81(8):736-43. doi: 10.1002/jps.2600810803. J Pharm Sci. 1992. PMID: 1403715
-
Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse.Skin Pharmacol. 1994;7(5):262-9. doi: 10.1159/000211303. Skin Pharmacol. 1994. PMID: 8054208
-
Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.Drug Dev Ind Pharm. 2006 Jun;32(5):595-607. doi: 10.1080/03639040600599848. Drug Dev Ind Pharm. 2006. PMID: 16720414
-
The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.G Ital Dermatol Venereol. 2018 Feb;153(1):102-106. doi: 10.23736/S0392-0488.17.05781-9. G Ital Dermatol Venereol. 2018. PMID: 29319278 Review.
Cited by
-
Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment.Drug Deliv Transl Res. 2013 Dec;3(6):587-92. doi: 10.1007/s13346-012-0083-1. Drug Deliv Transl Res. 2013. PMID: 25786376
-
Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth.Theranostics. 2016 Apr 11;6(6):817-27. doi: 10.7150/thno.14932. eCollection 2016. Theranostics. 2016. PMID: 27162552 Free PMC article.
-
Identification of Drugs that Regulate Dermal Stem Cells and Enhance Skin Repair.Stem Cell Reports. 2016 Jan 12;6(1):74-84. doi: 10.1016/j.stemcr.2015.12.002. Epub 2015 Dec 24. Stem Cell Reports. 2016. PMID: 26724904 Free PMC article.
-
Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation.Acta Derm Venereol. 2025 Apr 27;105:adv42401. doi: 10.2340/actadv.v105.42401. Acta Derm Venereol. 2025. PMID: 40289757 Free PMC article.
-
The enhancing effect of ion-pairing on the skin permeation of glipizide.AAPS PharmSciTech. 2009;10(3):967-76. doi: 10.1208/s12249-009-9283-5. Epub 2009 Jul 28. AAPS PharmSciTech. 2009. PMID: 19636711 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources